Cariglim MP 1mg/500mg/15mg Tablet
Marketer
Caris Labs LLP
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Cariglim MP 1mg/500mg/15mg Tablet
Metformin/Glimepiride/Pioglitazone 1mg/500mg/15mg tablets offer triple-action blood sugar management. This combination therapy, used alongside diet and exercise, improves glycemic control in adult type 2 diabetics. It enhances insulin effectiveness, reducing blood glucose. Dosage and duration should strictly follow your physician's instructions; take with food to minimize gastric distress. Missed doses should be taken promptly unless nearing the next scheduled dose, in which case it should be omitted. Never double the dose; overdose risks hypoglycemia (low blood sugar). Concurrent use with other diabetes medications, alcohol, or skipped meals increases hypoglycemia risk; regular blood glucose monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation before use. Renal function tests will be assessed before prescription. Limit alcohol consumption to mitigate potential side effects.
Primary Ingredients of Cariglim MP 1mg/500mg/15mg Tablet
No text provided to rephrase.
Uses of Cariglim MP 1mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Cariglim MP 1mg/500mg/15mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the Cariglim MP 1mg/500mg/15mg Tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with meals.
Common Side effects of Cariglim MP 1mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Cariglim MP 1mg/500mg/15mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the Cariglim MP 1mg/500mg/15mg Tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.
How Cariglim MP 1mg/500mg/15mg Tablet works:
Cariglim MP tablets (1mg/500mg/15mg) combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to optimize blood sugar management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, reducing blood glucose levels. Metformin, a biguanide, acts through multiple pathways: decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity. Finally, pioglitazone, a thiazolidinedione, further improves insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Combining Cariglim MP 1mg/500mg/15mg tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Cariglim MP 1mg/500mg/15mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible risks prior to prescription. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
Nursing mothers should likely avoid Cariglim MP 1mg/500mg/15mg tablets. Preliminary data from humans indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Cariglim MP 1mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Physician consultation is necessary. This medication is contraindicated in individuals with severe kidney disease. Close monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Cariglim MP 1mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. Cariglim MP 1mg/500mg/15mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Cariglim MP 1mg/500mg/15mg Tablet :
Should you forget a Cariglim MP 1mg/500mg/15mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Cariglim MP 1mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Medication |
3,018 People bought this recently